Nxera Pharma Co Ltd (SOLTF)
9.55
+0.25
(+2.65%)
USD |
OTCM |
May 03, 16:00
Nxera Pharma Total Liabilities (Quarterly): 640.94M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 640.94M |
| September 30, 2023 | 612.40M |
| June 30, 2023 | 285.92M |
| March 31, 2023 | 303.99M |
| December 31, 2022 | 316.38M |
| September 30, 2022 | 273.19M |
| June 30, 2022 | 255.25M |
| March 31, 2022 | 321.94M |
| December 31, 2021 | 343.40M |
| September 30, 2021 | 314.29M |
| June 30, 2021 | 231.51M |
| March 31, 2021 | 220.79M |
| December 31, 2020 | 233.52M |
| September 30, 2020 | 237.45M |
| June 30, 2020 | 94.23M |
| March 31, 2020 | 98.44M |
| December 31, 2019 | 106.54M |
| September 30, 2019 | 156.53M |
| June 30, 2019 | 157.10M |
| March 31, 2019 | 164.26M |
| September 30, 2018 | 156.45M |
| June 30, 2018 | 172.32M |
| March 31, 2018 | 193.85M |
| December 31, 2017 | 206.64M |
| September 30, 2017 | 211.55M |
| Date | Value |
|---|---|
| June 30, 2017 | 209.16M |
| March 31, 2017 | 176.46M |
| December 31, 2016 | 189.75M |
| September 30, 2016 | 204.27M |
| June 30, 2016 | 249.05M |
| March 31, 2016 | 214.29M |
| December 31, 2015 | 153.50M |
| September 30, 2015 | 159.51M |
| June 30, 2015 | 234.98M |
| March 31, 2015 | 274.86M |
| December 31, 2014 | 5.592M |
| September 30, 2014 | 4.588M |
| June 30, 2014 | 5.050M |
| March 31, 2014 | 2.208M |
| December 31, 2013 | 1.739M |
| September 30, 2013 | 3.456M |
| June 30, 2013 | 3.527M |
| March 31, 2013 | 7.089M |
| December 31, 2012 | 3.208M |
| September 30, 2012 | 2.462M |
| June 30, 2012 | 4.428M |
| March 31, 2012 | 7.666M |
| December 31, 2011 | 3.588M |
| September 30, 2011 | 4.429M |
| June 30, 2011 | 4.673M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
94.23M
Minimum
Jun 2020
640.94M
Maximum
Dec 2023
273.88M
Average
255.25M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 53.04B |
| PeptiDream Inc | 206.45M |
| Stemcell Holdings Inc | 6.023M |
| Healios KK | 80.04M |
| AnGes Inc | 19.78M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.115B |
| Shareholders Equity (Quarterly) | 473.75M |
| Debt to Equity Ratio | 1.035 |
| Current Ratio | 3.789 |
| Net Debt Paydown Yield | -6.66% |